These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1502015)

  • 1. Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.
    Löscher W
    Pharm Weekbl Sci; 1992 Jun; 14(3A):139-43. PubMed ID: 1502015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-2-en-valproate: reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs.
    Löscher W; Hönack D; Nolting B; Fassbender CP
    Epilepsy Res; 1991 Sep; 9(3):195-210. PubMed ID: 1743183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.
    Keane PE
    Pharm Weekbl Sci; 1992 Jun; 14(3A):144-5. PubMed ID: 1354349
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
    Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication.
    Löscher W; Nau H; Wahnschaffe U; Hönack D; Rundfeldt C; Wittfoht W; Bojic U
    Epilepsy Res; 1993 Jun; 15(2):113-31. PubMed ID: 8370349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
    Löscher W; Nau H; Marescaux C; Vergnes M
    Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.
    Luder AS; Parks JK; Frerman F; Parker WD
    J Clin Invest; 1990 Nov; 86(5):1574-81. PubMed ID: 2243131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice.
    Keane PE; Simiand J; Morre M
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):83-6. PubMed ID: 2859407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
    Tang W; Borel AG; Fujimiya T; Abbott FS
    Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Dev Pharmacol Ther; 1992; 19(4):196-204. PubMed ID: 1343622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats.
    Safar MM; Abdallah DM; Arafa NM; Abdel-Aziz MT
    Brain Res; 2010 Jun; 1334():58-64. PubMed ID: 20353763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.
    Kassahun K; Hu P; Grillo MP; Davis MR; Jin L; Baillie TA
    Chem Biol Interact; 1994 Mar; 90(3):253-75. PubMed ID: 8168173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
    Bolaños JP; Medina JM
    Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.
    Scism JL; Powers KM; Artru AA; Chambers AC; Lewis L; Adkison KK; Kalhorn TF; Shen DD
    Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?
    Cuadrado A; Amat G; Armijo JA
    Pharmacol Res; 2003 Aug; 48(2):183-92. PubMed ID: 12798671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.